Kinetic Analysis of Malignant Fibrous Histiocytoma Cells Treated with Anticancer Agents In Vivo.
-
- Egawa Masaaki
- Department of Orthopaedic Surgery, Shiga University of Medical Science
-
- Chano Tokuhiro
- Department of Orthopaedic Surgery, Shiga University of Medical Science
-
- Matsumoto Keiji
- Department of Orthopaedic Surgery, Shiga University of Medical Science
-
- Okabe Hidetoshi
- Department of Clinical Laboratory Medicine, Shiga University of Medical Science
-
- Ishizawa Michihito
- Department of Orthopaedic Surgery, Shiga University of Medical Science
-
- Hukuda Sinsuke
- Department of Orthopaedic Surgery, Shiga University of Medical Science
Search this article
Abstract
To clarify the in vivo effects and the changes in kinetic parameters of soft tissue sarcoma caused by anticancer agents, we performed double-labeling using bromo- (BrdU) and iododeoxyuridine (IUdR). A malignant fibrous histiocytoma cell line was transplanted into nude mice, and treated with 3 anticancer agents: cisplatin, doxorubicin and vincristine. The following parameters were determined: BrdU labeling index (LI), duration of S-phase (Ts), total cell cycle time (Tc), Ki-67 labeling index (KLI), PCNA labeling index (PCNA-LI), and actual tumor volume doubling time (Tv). In addition, the apoptotic cell ratio (apoptotic index; Al) was calculated in the serial specimens using terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL).<br>Vincristine inhibited the tumor growth the most effectively (Tv: -5.8 days). Doxorubicin suppressed the tumor growth better (Tv: 12.7 days) than cisplatin (Tv: 9.1 days). Tc values showed significant differences among the drug groups (ANOVA analysis; p<0.05), and also correlated with Tv (Pearson's analysis; R>0.7, p<0.05) on Day 1. Al peaked on Day 10 and decreased afterward in every drug group.<br>Anticancer agents effectively suppress tumor growth not only by necrosis and apoptosis, but also by prolonging Tc. Tc values are possibly useful for planning chemotherapy for sarcoma patients.
Journal
-
- ACTA HISTOCHEMICA ET CYTOCHEMICA
-
ACTA HISTOCHEMICA ET CYTOCHEMICA 32 (5), 437-443, 1999
JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679837518592
-
- NII Article ID
- 110003147058
-
- NII Book ID
- AA00508022
-
- COI
- 1:CAS:528:DC%2BD3cXpt1Shsw%3D%3D
-
- ISSN
- 13475800
- 00445991
- http://id.crossref.org/issn/00445991
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- NDL-Digital
- CiNii Articles
-
- Abstract License Flag
- Disallowed